Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : | NSE Symbol : | ISIN : | Industry : |

(23-Jul-25 15:45) Biocon Biologics appoints Deepali Naair as Global Head – Brand & Corporate Communications
(23-Jul-25 09:00) Biocon Biologics launches biosimilar - Nepexto® in Australia
(07-Jul-25 12:36) Biocon Biologics receives UK MHRA marketing authorisations for Vevzuo® and Evfraxy®
(03-Jul-25 09:12) Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
(30-Jun-25 09:06) Biocon Biologics expands access to insulin in Malaysia
(24-Jun-25 09:11) Biocon Biologics partners with National Cancer Society of Malaysia
(22-May-25 09:19) Biocon Biologics announces extension of insulin supply agreement with Govt. of Malaysia
(21-May-25 14:47) Biocon Biologics and Yoshindo Inc. launch Ustekinumab Biosimilar in Japan
(05-May-25 09:07) Biocon Biologics secures multiple market access agreements for Yesintek™
(15-Apr-25 09:29) Biocon Biologics inks a settlement and license agreement with Regeneron

1 2